Fredun Pharmaceuticals informs about outcome of board meeting

28 Jan 2023 Evaluate

Fredun Pharmaceuticals has informed that the Board of Directors of the company, at their Meeting held on Friday, 27th January, 2023 had considered and approved the following item: In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended 31st December 2022 along with the Limited Review Report as issued by Savla & Associates, Statutory Auditors of the Company; copies of which are attached. The Meeting of the Board Commenced at 2.00 pm and concluded at 08:00 pm.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

653.80 8.70 (1.35%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...